• Management Fellowship - Cell Therapies

    Location US-MA-Boston
    Job Posted Date 3 months ago(1/27/2019 9:34 PM)
    Job ID
    full time
  • Overview

    Dana-Farber Cancer Institute (DFCI), a world-renowned Comprehensive Cancer Center located in the heart of Boston’s medical area, is seeking applicants for its 2019 - 2020 Stem Cell Transplant and Cellular Therapies Management Fellowship Program.


    The Management Fellowship is a one-year program designed to provide high potential individuals with the opportunity to further develop their leadership style, management expertise, and analytical skills while gaining specific expertise in managing the resources and activities required for the success of the Stem Cell Transplant and Cellular Therapies service line. The Management Fellowship provides the opportunity to obtain an applied foundation across a spectrum of services and locations that support a fast-growing treatment paradigm in oncology while experiencing first-hand an understanding of the common values shared by all health care professionals at Dana-Farber Cancer Institute.


    Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.

    The stem cell transplantation programs at Dana-Farber/Brigham and Women’s Cancer Center and Boston Children’s are among the largest and most experienced programs in the world. These programs combine major basic, translational, and clinical research programs to continuously improve and provide new therapies for patients.  These programs have performed more than 11,500 transplants for the treatment of blood cancers and related disorders since they began in 1972, originally as a joint program, and have made major contributions to the advancement of research and care across many diagnoses. The programs have tracked and provided valuable data to the Center for International Blood & Marrow Transplant Research (CIBMTR), the official U.S. repository for stem cell transplantation and cellular therapies, since its inception and consistently exceed expected outcomes set by the CIBMTR.


    The HSCT and IEC therapies programs evaluate more than 1000 patients/year and currently perform approximately 500 adult, 140 pediatric transplants, and 150 CAR-T procedures annually. There are more than forty (40) credentialed physicians, with many holding leadership roles in national organizations and playing key editorial contributor roles for the most cited journals in the field. The research enterprise and facilities are considered national benchmarks among NIH Comprehensive Cancer Centers, and consistently deliver novel and pioneering experimental therapies.  DFCI participates with top research institutions, universities, industry and hospitals through important affiliations and collaborative relationships to drive the advancement of cancer care at the national and international level. The programs are served by an all new (opened in August 2018), state of the art, 34,000 sq. ft. cellular processing and novel cell manufacturing laboratory.




    The Fellowship will begin with a two-month rotation and shadow experience with leaders for each of the major areas serving the Stem Cell Transplant and Cellular Therapies Enterprise based at Dana-Farber. After the rotation and for the duration of the Fellowship, the Fellow will be assigned to a series of management responsibilities and high-visibility projects to provide them with an opportunity to make significant contributions in diverse areas, including:


    • Operations Effectiveness, Process Improvement, and Resource Utilization Analytics
    • Strategic Planning, Network Development Assessment and Communications and Marketing
    • Implementation of Treatment Consensus Standards and Pathways
    • Inpatient and Ambulatory Clinical Operations supporting Stem Cell Transplant and Cellular Therapies
    • Revenue Cycle and Financial Planning
    • Donor Services, Cellular Therapies Supply Chain and Logistics
    • Quality Assurance/Control and Patient Safety
    • Regulatory Compliance and Outcomes Reporting
    • Information Systems Supporting the Cell Therapies Enterprise


    The Administrative Fellow will report to the VP of the Division of Stem Cell Transplantation and Cellular Therapies who will provide valuable mentoring and strategic guidance on project involvement and ensure full engagement across assigned areas over the course of the fellowship. The Fellow will also have direct access to senior-level faculty and management to ensure additional mentorship.


    Requirements:  Highly motivated individuals with a master's degree  in health care administration, business administration, public health, or related fields of study.   Ideal candidates  will have experience within the healthcare industry, possess a broad understanding of the U.S. healthcare system, are collaborative, excellent communicators, and self-starters.


    • Fellowship Dates: July 1, 2019-June 30, 2020


    Application Requirements and Deadline

    To be considered for this opportunity, please submit a  resume by February 20, 2019. Candidates who are selected to advance will be asked to submit the following by March 1, 2019:

    • Personal statement of interest in the Fellowship and how it would further the applicant’s career objectives (maximum of 2 pages, double-spaced)
    • Written response to what strengths the applicant believes to be most valuable for the Management Fellowship(300-word limit)
    • Official graduate school transcript
    • Three letters of recommendation, one of which must be from a faculty member at the graduate institution



    Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed

    Connect With Us!

    Not ready to apply? Connect with us for general consideration.